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Abstract
Background: The rates of diabetes and prediabetes in the USA are growing, significantly impacting the quality and
length of life of those diagnosed and financially burdening society. Premature death and disability can be prevented
through implementation of evidence-based programs and policies (EBPPs). Local health departments (LHDs) are uniquely
positioned to implement diabetes control EBPPs because of their knowledge of, and focus on, community-level needs,
contexts, and resources. There is a significant gap, however, between known diabetes control EBPPs and actual diabetes
control activities conducted by LHDs. The purpose of this study is to determine how best to support the use of evidence-
based public health for diabetes (and related chronic diseases) control among local-level public health practitioners.
Methods/design: This paper describes the methods for a two-phase study with a stepped-wedge cluster randomized
trial that will evaluate dissemination strategies to increase the uptake of public health knowledge and EBPPs for
diabetes control among LHDs. Phase 1 includes development of measures to assess practitioner views on and
organizational supports for evidence-based public health, data collection using a national online survey of LHD chronic
disease practitioners, and a needs assessment of factors influencing the uptake of diabetes control EBPPs among LHDs
within one state in the USA. Phase 2 involves conducting a stepped-wedge cluster randomized trial to assess
effectiveness of dissemination strategies with local-level practitioners at LHDs to enhance capacity and organizational
support for evidence-based diabetes prevention and control. Twelve LHDs will be selected and randomly assigned to
one of the three groups that cross over from usual practice to receive the intervention (dissemination) strategies at
8-month intervals; the intervention duration for groups ranges from 8 to 24 months. Intervention (dissemination)
strategies may include multi-day in-person workshops, electronic information exchange methods, technical assistance
through a knowledge broker, and organizational changes to support evidence-based public health approaches.
Evaluation methods comprise surveys at baseline and the three crossover time points, abstraction of local-level
diabetes and chronic disease control program plans and progress reports, and social network analysis to understand
the relationships and contextual issues that influence EBPP adoption.
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Background
With more than 30 million people in the USA diagnosed
with diabetes and 84.1 million with prediabetes [1], the bur-
den on individuals, families, communities, and society is
substantial. Racial, ethnic minority and lower socioeco-
nomic groups bear a disproportionate burden with higher
rates of prevalence and complications [2]. In addition to the
health impact, medical spending per person in the USA due
to diabetes doubled between 1987 and 2011 [3]. The health
and financial impact call attention to the greater need for
and potential economic return of diabetes control efforts
[4]. Diabetes control encompasses primary prevention, i.e.,
promotion of physical activity, healthy eating, obesity pre-
vention, secondary prevention, i.e., early detection, self-
management. Obesity, unhealthy eating, and physical
inactivity account for more than half of new diabetes cases
[5, 6]. If addressed, this could have a profound effect on
health disparities, incidence of diabetes as well as cardiovas-
cular diseases, some cancers, and other chronic conditions,
and quality and length of life of those diagnosed [7–10].
Practitioners in the 2800 US local health departments
(LHDs) are ideally positioned to affect programs and pol-
icies related to diabetes control because of their knowledge
of, and focus on, community-level needs, contexts, and re-
sources as well as their key role interfacing with health care
providers [11, 12]. These attributes allow for LHDs to assess
a public health problem, adapt an appropriate program or
policy, cultivate partnerships, and assure research-tested
interventions—or evidence-based programs and policies
(EBPPs) are effectively delivered and implemented [13–16].
LHDs are playing an increasing role in diabetes control
through activities such as obesity prevention [17, 18], dia-
betes self-management [19, 20], and development of regis-
tries to monitor diabetes at a population-level and intervene
in a timely and targeted manner [21]. A pilot study of LHDs
in Missouri assessed the use of 20 diabetes-related EBPPs,
feasibility of EBPPs, and personal/organizational barriers to
evidence-based practice [22].
Research has demonstrated that simply making EBPPs
available for adoption is not sufficient to assure their
widespread use [23–25]. Many local public health practi-
tioners are aware of EBPPs, but lack the needed skills to
adapt and use them or face organizational barriers to their
use [26–30]. To improve practice, LHD professionals need
evidence-based information to make decisions on how to
improve public health system performance and health out-
comes [31]. Evidence-based public health is the process of
integrating science-based interventions with community
preferences to improve the health of populations [31–34].
A key aspect of evidence-based public health is evidence-
based decision-making (EBDM), which involves making de-
cisions based on the best available scientific or rigorous pro-
gram evaluation evidence, applying program planning and
quality improvement frameworks, engaging the community
in assessment and decision-making, adapting and imple-
menting EBPPs for specific populations or settings, and
conducting sound evaluation [30, 33, 35, 36]. In support of
EBDM, there are numerous analytic tools now available to
increase the use of evidence-based diabetes-related inter-
ventions (e.g., the Community Guide, What Works for
Health) [37, 38].
The gap between research and practice underscores the
need to understand barriers and facilitators to dissemin-
ation and uptake of evidence into practice. In a study from
Brownson and colleagues in two US states, participants
identified communication with policymakers, use of eco-
nomic evaluation, and translation of research to practice as
top competency gaps for evidence-based public health [39].
Lack of incentives, inadequate relationships between people
involved in research and practice, and absence of cultural
and managerial support and supportive organizational cli-
mates are among the most commonly cited barriers [30, 32,
40–45]. Studies have found a strong link between the per-
ception of organizational priority for evidence-based prac-
tices and use of research to inform program adoption and
implementation [29, 41]. Relationships among health de-
partments can facilitate dissemination of program and pol-
icies, including diabetes EBPPs [46–48]. In addition,
relationships among staff within health departments and
between health departments and local stakeholders are es-
sential to successful implementation of public health pro-
grams [49, 50].
Thus, to enhance adoption of evidence-based approaches,
active and multi-modal strategies are needed to build local-
level public health workforce capacity and organizational
support to plan, implement, evaluate, and spread EBPPs for
diabetes control. Recent work to increase the use of EBPPs
for chronic disease prevention among state health depart-
ment practitioners utilized multiple active dissemination
strategies, including multi-day in-person evidence-based
decision-making workshops, supplemental webinars, and
strategies to ingrain EBDM into agency processes [51, 52].
The goals of this multi-phase study are to determine
effective ways to increase awareness and skills of local-
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level public health practitioners to apply EBDM prac-
tices and EBPPs for diabetes and other chronic disease
control, increase LHD agency and employee-level use of
EBDM practices to control diabetes and chronic diseases
in Missouri, and increase agency level sharing of effect-
ive approaches and EBPPs with partnering organizations.
Methods/design
Study design
This multi-phase dissemination study funded by the
National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK) evaluates the adoption and applica-
tion of EBDM practices and EBPPs for diabetes control
among LHDs. The study is guided by a transdisciplinary
team working in dissemination and implementation re-
search, evidence-based diabetes control, and collabora-
tive research with LHDs as well as partners serving
LHDs and local-level public health practitioners. This
study involves two complementary, overlapping phases.
Phase 1 includes development of a survey to collect
self-report data, refinement of record review and ab-
straction methods to collect objective data, and a local-
level needs assessment that includes qualitatively asses-
sing agency and broader system factors that facilitate or
hinder dissemination of EBPPs for diabetes and chronic
disease control in LHDs in Missouri. In addition,
phase 1 involves collection of self-report data from a
national sample of LHD practitioners working in
chronic disease control. Phase 2 is a stepped-wedge
cluster randomized controlled study designed to assess
effectiveness of the identified dissemination strategies
on local-level practitioners working in diabetes and
chronic disease control at 12 LHDs in Missouri. This
involves the selection of 12 LHDs in Missouri that are
randomized into one of three groups that receive the
intervention, i.e., dissemination strategies, for varying
durations ranging from 8 to 24 months. Dissemination
strategies may include training in evidence-based public
health, technical assistance through a knowledge
broker, providing targeted messages/emails with a short
summary of the research and actions that might be
taken based on the evidence, and organizational
changes to assist agency leadership in prioritizing, in-
centivizing, enhancing capacity for, and incorporating
the use of EBPPs. Study collaborators include the Na-
tional Association of County and City Health Officials
(NACCHO) and the Missouri Association of Local Pub-
lic Health Agencies (MoALPHA). The study was ap-
proved by the institutional review board of Washington
University in St. Louis. Some parts of phase 1 have
been completed, and phase two planning is underway.
Phase 2 is registered as a stepped-wedge cluster ran-
domized trial (clinicaltrials.gov NCT03211832).
The theoretical underpinning for the study is the Diffu-
sion of Innovation Theory [53], augmented by Institutional
Theory [54–56] as depicted in Fig. 1. In the context of this
study, EBPPs are the innovations, i.e., the idea or practice
that is perceived as new. The decision to adopt, accept, and
use an innovation is a process, and each stage of the frame-
work has specific characteristics (see Additional file 1). An
important aspect of this study’s framework is the contextual
factors affecting dissemination (Fig. 1b). Individual factors
can reflect the skills, knowledge, leadership, or commit-
ment of the individuals involved in dissemination. Institu-
tional theory draws upon a wide range of disciplines (e.g.,
economics, political science) to understand how social, gov-
ernmental, political, and commercial institutions influence
decision-making [57]. This theory explains that it is not
only how individuals make decisions that influence out-
comes, but also the rules that govern behavior, including
formal explicit rules such as regulations and laws, and im-
plicit rules like social norms and conventions, and self-
imposed codes of conduct [58]. Key concepts from Institu-
tional Theory that have contributed to the conceptual
framework, activities, and measures are organizational sup-
port for EBPPs, incentives to utilize EBPPs, social accept-
ability of EBPPs, and bi-directionality of organizational
change, i.e., the way organizations influence employees and
vice versa [58, 59]. In addition, intervention characteristics,
including feasibility, adaptability, and costs, are hypothe-
sized to influence dissemination stage. These factors will be
addressed in the menu of intervention strategies and evalu-
ation plan.
The study team will work in partnership with local-level
employees to assess contextual and organizational factors
that influence adoption and use of EBPPs, and jointly plan
the menu and implementation of interventions. Evaluation
will include survey measures taken at pre-intervention,
i.e., baseline, and at the three 8-month intervals during
the study intervention period, and process evaluation in
LHDs during the intervention period.
Study audience
The audience is LHD practitioners working in diabetes
and chronic disease control, including diabetes prevention
and management, obesity prevention, physical activity, nu-
trition, cardiovascular health, and cancer screening, and
their supervisors and agency leaders. The audience will be
drawn from diverse backgrounds including health educa-
tors, epidemiologists, and community health nurses. Pre-
vious research has shown larger LHDs have staff who
specialize in diabetes control whereas smaller LHDs typic-
ally employ more general chronic disease staff [60]. For
measures development in phase 1, the study audience is
LHD chronic disease control practitioners and supervisors
from across the USA. For phase 2, the audience is local-
level practitioners in Missouri LHDs. We will also focus
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on key partners for diabetes and chronic disease control
in the local community, including non-governmental
agencies (e.g., local hospitals, community-based organiza-
tions) and governmental agencies outside of the health
sector (e.g., universities, parks and recreation, schools).
Phase 2 will include a primary and secondary group in
each LHD. The primary group will be made up of individ-
uals who attend the initial intervention strategy, a targeted
multi-day workshop in evidence-based public health. The
secondary group will include other LHD staffs who sup-
port chronic disease control and staff from key partner
agencies because they are expected to apply EBPPs for
chronic diseases control as guided by the LHD and to
meet sample size requirements.
Phase 1: development of measures, local-level needs
assessment
In phase 1, the study team will develop and test a survey
instrument. Self-report survey data will be collected na-
tionally, and the study team will refine a tool to abstract
local health department plans and progress reports as
objective data of planning and implementation of EBPPs
in diabetes and chronic disease control.
Survey instrument
The measures to assess the dissemination of EBPPs for
chronic disease prevention are under-developed [61, 62]
particularly among LHDs [63–65]. The primary objective
is to develop a survey tool to collect key measures in
phase 2. To improve the external validity of the mea-
sures [66], the survey tool will be developed at the
national level. This will also provide a national picture of
local-level practitioner views on EBPPs and EBDM, im-
plementation of EBPPs among LHDs, training and infor-
mational needs for EBDM, organizational support for
EBDM, barriers to EBDM, and local-level relationships
including the characteristics of academic partnerships.
Measures
The survey was developed from previous research con-
ducted by the project team [30, 39, 51, 67–70], abstract-
ing data from existing instruments identified through
snowball sampling of the study team, and three rounds
of input from November 2016–January 2017. The survey
has nine sections and 86 items and was designed to be
completed in 20 min. Table 1 displays the survey sec-
tions, types of items, and their sources. Based on survey
data, four dependent variables will be created to tie dir-
ectly with the dissemination stage within the study’s con-
ceptual framework (Fig. 1a), i.e., awareness, adoption,
implementation, and maintenance. The survey includes
the Short Grit Scale, which measures passion and perse-
verance for long-term goals [71]. The construct of grit
has been identified as a factor related to overall perform-
ance in several different populations [71], and recent re-
search found grit to be positively associated with
implementing and sustaining evidence-based interven-
tions among front-line therapists treating substance
abuse disorders [72]. The study team developed two
items on health equity in programs, policies, and ser-
vices, which were included in the section, Views on
EBPPs. The survey instrument was programmed in
Fig. 1 Conceptual framework of dissemination of EBPPs in LHDs
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Qualtrics online survey software and went through sev-
eral iterations of review and refinement with research
staff before cognitive response and reliability testing.
Survey instrument testing
Cognitive response testing
Survey items were revised through cognitive response
testing, which has been shown to improve survey devel-
opment and the quality of data collection [73]. Ten local
public health practitioners working in diabetes and
chronic disease control at LHDs across the USA identi-
fied by a partner organization completed hour-long
phone interviews in February and March 2017.
Interviews were conducted by the project manager and
involved reviewing survey items with participants. Par-
ticipants provided feedback on question comprehension
(what the participant thought the question was asking,
question wording clarity) and information retrieval and
decision processing (questions that were clear but diffi-
cult to answer). In addition, participants shared input on
the relevance of EBPPs to local-level practitioners and
LHDs. Interview participants were offered a $20 Ama-
zon.com gift card for completion of the cognitive re-
sponse testing. Interviews were audio-recorded and
reviewed to identify themes that occurred in two or
more interviews. A summary report was reviewed by the
study advisory group who refined item wording.
Reliability test-retest
A list of 100 LHDs was randomly selected from LHDs
who completed the 2016 NACCHO National Profile and
reported that their LHD screens for diabetes or body mass
index (BMI) or conducts population-based primary pre-
vention activities for nutrition or physical activity. The
lead chronic disease control staff person was identified for
each LHD selected. Respondents that completed the sur-
vey the first time were emailed an invitation to take the
survey again 14–21 days after their initial survey. Efforts
were made to distribute the sample across LHD jurisdic-
tion population size (small < 50,000, medium 50,000–
199,999, and large ≥ 200,000). Replacement sampling was
done as needed to get close to 100 eligible invitees. Of the
97 eligible practitioners invited, 56 completed test 1
(57.7% response rate), and 53 completed test 2 (94.6% of
test 1). Respondents completed the second survey 15 to
36 days after the first survey.
Statistical analyses for test-retest included calculating
intra-class correlation coefficients (ICC) for Likert scale
items and percent agreement and Cohen’s kappa statistic
for dichotomous items and dichotomized Likert-scale items
(strongly agree and agree vs. other responses). Cronbach’s
alpha was calculated to test internal consistency of the do-
main and influence of individual items on a domain for
each continuous variable. For ranking items, the percent
agreement of the three items chosen in the top three in test
Table 1 Survey measures
Survey section Number
of items
Types of variables Sample items Item sources
Background 9 Check one, years,
check all that
apply, yes/no
Position, years in position, degree/credentials,
gender, race/ethnicity, age, program areas
Jacobs 2010
EBPPs to address chronic




Asked 1 topic: diabetes control, obesity
prevention, physical activity, nutrition, or tobacco
control
Has your agency directly delivered? (4 items)
Has your agency collaborated with
organization(s) to support delivery? (4 items)
Community guide, What works
for health, Guide to clinical
preventive services
Views on EBPPs 6 Likert 7-point scale,
text/short answer
Program staff in my work group/division is aware
of toolkits for planning and evaluation.
Health equity (2 items)
Jacobs 2010, Reis 2014
New
EBDM definitions and supports 2 Rank top 3 Which of the following would be most useful to
you in building skills for EBDM?
Jacobs 2012, Reis 2014







Spreading EBDM 26 Likert 7-point scale Dissemination stages (22 items)
Administrative evidence-based practices (4 items)
Stamatakis 2017, Brownson 2012,
2013
Ending programs 4 Select top 3, how
often
Reasons for programs ending that should have
continued, reasons for continuing programs that
should have ended
Brownson 2015
Work style 8 Likert 5-point scale Short Grit Scale Duckworth 2009
Academic partnerships 2 Yes/no/unsure,
check all that
apply
Does your agency currently participate in any
academic partnerships?
New
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1 and test 2 was calculated. Landis and Koch [74] kappa
categories of almost perfect (1.0–0.8), substantial (0.8–0.6),
moderate (0.6–0.4), fair (0.4–0.2), and low (0.2–0.0) were
used to interpret the results. For ICCs and percent agree-
ment, > 0.60 was considered desirable and > 0.70 was good,
respectively [75]. Test-retest results showed that percent
agreements were typically ≥ .70 and ICCs, the best fitting
statistic for most sections and items, were mostly ≥ .60. The
majority of kappa coefficients were in the moderate and
substantial ranges (0.4–0.6 and 0.6–0.8). Most of the scales
showed good internal consistency (Cronbach’s alpha > .80).
Based on the review of test-retest results, the wording of
eight items was revised, and one item was split into two.
Since the survey was only slightly modified, test 1 surveys
will be combined with the full survey sample data described
below for almost all items.
Survey participant recruitment
Figure 2 depicts the selection of LHD lead practitioners
working in chronic disease control for the national survey,
similar to reliability test-retest selection mentioned previ-
ously. Efforts were made to distribute the sample across
LHD jurisdiction population size. Data will be collected
using Qualtrics online survey software. Pre-invitation
emails, informing survey contacts about the study purpose,
will be sent 1 week prior to sending the survey invitations,
which will also include study information and the survey
link. Follow-up to non-respondents will include three re-
minder emails and two follow-up calls. Respondents will be
offered a $20 Amazon.com gift card for completing the sur-
vey. A survey response rate of 66.7% is anticipated.
Program record review tool development
Phase 1 includes the development and testing of a tool
and codebook for record abstraction of LHD plans and
reports for diabetes control. The purpose is to supple-
ment the self-reported data on EBPPs being planned and
implemented for diabetes control in the twelve partici-
pating LHDs (phase 2). To draft the record abstraction
tool and codebook, the study team will abstract work
plans, strategic plans, and reports from 25 LHDs that
participate in the national survey. The Community
Guide [76], What Works for Health [38], and The Guide
for Clinical Preventive Services [77] will be the basis for
EBPP inclusion on the tool for program areas. Currently,
there are no systematic records among LHDs in Mis-
souri capturing diabetes prevention and management ef-
forts; however, the study team will proceed with
abstracting LHD work plans, strategic plans and pro-
gress reports in diabetes prevention and management,
obesity prevention, physical activity, nutrition, and to-
bacco control from the selected LHDs during pre-
intervention (baseline) and after dissemination strategies
are applied.
Local-level needs assessment
Since diabetes control covers an array of risk factors, demo-
graphic considerations, and intervention approaches, we
conducted a needs assessment with LHDs in Missouri to
narrow, prioritize, and tailor approaches to LHDs in Mis-
souri. This will allow us to refine the menu of dissemin-
ation strategies for use in phase 2. The needs assessment
process included compiling and organizing diabetes mortal-
ity, prevalence and incidence, and risk factor data for Mis-
souri counties into tables and maps to analyze the burden
of diabetes, and organizing potential interventions by dia-
betes risk factors. In addition, we conducted qualitative
phone interviews of key informants to assess organizational,
inter-organizational, and broader contextual factors that fa-
cilitate or hinder dissemination and implementation of
EBPPs for diabetes and chronic disease control. Among the
115 LHDs in Missouri, we conducted 24 1-hour, key in-
formant interviews from 14 LHDs in January–April 2017
(14 local health directors, and 10 employees/practitioners
who lead diabetes or chronic disease control for their
LHD). The interviews were audio-recorded, transcribed
verbatim, and reviewed for completeness and accuracy. In-
terviews were coded by two coders using a consensus cod-
ing approach. The coding approach included segmentation
of text using the interview guide to establish major categor-
ies, codebook development, coding, assessment of reliabil-
ity, codebook adjustment, and final coding with iterative
modifications [78–81]. Themes will be identified, and a
summary report that includes a list of potential dissemin-
ation activities will be developed and shared with the study
advisory committee, which will include practitioner part-
ners and participating LHD designees. The advisory com-
mittee will be asked to rate the usefulness and feasibility of
each possible dissemination activity. This rating process will
allow us to tailor intervention activities to LHDs’ priorities
and needs. This is likely to increase the effectiveness and
sustainability of dissemination approaches.
Phase 2: dissemination with local health departments
Overview
Phase 2 will be a stepped-wedge cluster randomized evalu-
ation study to assess the effectiveness of active dissemin-
ation approaches on local-level practitioners to increase
adoption and use of EBPPs for diabetes and chronic disease
control among LHDs in Missouri. Figure 3 depicts the
phase 2 stepped wedge design and implementation during
the study. Unlike parallel trials, the stepped wedge design
randomly assigns clusters to the order of implementation
such that all clusters eventually receive the intervention
[82]. This design has been primarily used to evaluate inter-
ventions during routine implementation, mainly for inter-
ventions where there is lack of evidence of effectiveness but
there is a strong belief the intervention will do more good
than harm [83], which was deemed the instance for this
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study by the study team and advisory group. The clusters
are LHDs and are made up of individual employees working
in or supporting diabetes or chronic disease control. We
will select and recruit 12 LHDs from the 115 LHDs in Mis-
souri. LHDs will be randomly assigned to three groups that
cross over from the control, i.e., usual practice, to partici-
pate in the intervention with measurements at 8-month in-
tervals. No LHDs receive the intervention at baseline. All
participating 12 LHDs will participate in the intervention,
however, for varying durations; group 1 crosses over to re-
ceive the intervention activities first, and for a total of
24 months, group 2 crosses over second (at 11 months) and
receives the intervention for 16 months, and group 3
crosses over last (at 19 months) and receives the
intervention activities for 8 months. The intervention activ-
ities seek to build workforce and organizational capacity
and to effectively package and provide information so that it
is timely, relevant, and useful for various local-level practi-
tioners. A menu of dissemination strategies co-developed
by the advisory group and study team will be offered and
then selected by each LHD. Evaluation measures will in-
clude the survey and record abstraction tool developed in
phase 1 and social network analyses.
Local health department selection and recruitment
LHD selection will be based in part on the total number
of full-time equivalent (FTE) employees (number of FTEs
increases with size of population served by LHD [84]),
Fig. 2 Phase 1 national survey selection of LHD lead practitioners working in chronic disease control
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number of employees working in or supporting diabetes
or chronic disease control, and diabetes burden, specific-
ally mortality rate for diabetes as underlying cause (a
measure of health disparity). Of the 12 LHDs selected and
recruited, at least three will come from LHDs in counties
from the highest tertile of mortality rate for diabetes as
underlying cause. To be eligible, LHDs are required to
have ≥ 5 employees working in or supporting diabetes or
related areas in chronic disease control, which includes
program areas of diabetes prevention and management,
obesity prevention, physical activity, nutrition, cardiovas-
cular health, school health, and cancer screenings. In
addition, each LHD must have a designee to work with
the study team on aspects of the intervention. LHDs will
be assigned to one of the three groups (four LHDs to each
group) using simple random concealed allocation per-
formed by the statistician (YY).
Based on our preliminary studies and values of ICC in
the literature [29, 30, 85–90], we estimated a range of ef-
fect sizes and ICCs. We calculated a median ICC from
similar studies and developed a range based on a 50% de-
crease and increase around the median (range 0.009 to
0.027). Using previous work with LHD practitioners on
EBDM competency gaps, i.e., needed but unavailable skills
[90], the sample size was based on testing two hypotheses:
(1) the null hypothesis of a change in mean EBDM com-
petency gap score for a single competency (action plan-
ning) from baseline in both control and intervention
conditions is 0.03, and the alternative hypothesis of a
change in mean competency gap score for action planning
in intervention condition is 1.000 (common SD = 2.3) and
(2) the null hypothesis of a change in mean EBDM com-
petencies summary gap score from baseline in both con-
trol and intervention conditions is 0.4, and the alternative
hypothesis of a change in mean summary gap score in
intervention condition is 6.1 (common SD = 18.5). Follow-
ing Baio et al. [91], 12 LHDs with 3 steps (or groups of 4
LHDs each) and 20 subjects in each LHD (total = 240),
using the conservative estimate of ICC at 0.02 with two-
sided 5% significance level, will give more than 95% of
power to reject the first null hypothesis, and 80% of power
to reject the second null hypothesis.
LHDs with a total number of FTEs ≥ 35 or serving a
population of ≥ 200,000 are anticipated to have an adequate
number of employees working in diabetes and chronic dis-
ease control. The project manager (RP) contacted directors
at LHDs with 25–34 FTEs and serve a population of <
200,000 (8 LHDs) to determine if their LHD has ≥ 5 em-
ployees working in diabetes prevention and management,
obesity prevention, physical activity, nutrition, cardiovascu-
lar health, or cancer screenings; 5 of the 8 LHDs met this
criterion. Of eligible LHDs (17 of 115 LHDs), those with
the greatest diabetes burden (i.e., in the highest tertile for
mortality rate for diabetes as underlying cause) followed by
LHDs with the largest total number of FTE employees will
be contacted and recruited. Random assignment of the first
Fig. 3 a Phase 2 stepped wedge study design. b Stepped wedge implementation during study
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12 selected LHDs to groups will be performed. The princi-
pal investigator will invite local health directors from each
selected LHD to have their employees working in diabetes
and chronic disease control participate in the study. If any
LHD declines, the next LHD according to total number of
FTE employees will be selected. All employees working in
or supporting diabetes and chronic disease control in par-
ticipating LHDs will be invited into the study (complete list-
ing), and a purposive sample of individuals from partner
agencies (other governmental and non-governmental) in
each LHD local community will also be invited. LHDs’ key
partners will be recruited into the study with the help of
the chronic disease managers and other practitioners. We
anticipate a range of 5 to 22 participants from the LHDs,
coupled with staff from partner agencies for an average of
22 per jurisdiction.
Dissemination strategies
In each LHD, a primary group of employees working in or
supporting diabetes and chronic disease control and staff
from key partnering agencies will collaborate to select and
refine dissemination strategies relevant to their agency’s
priorities, as well as community and broader contexts.
The objective is to enhance the capacity of local-level
practitioners; their work group/division and overall LHD
to plan, implement, evaluate, and spread EBPPs for dia-
betes and chronic disease control. There will be a menu of
dissemination intervention activities from which LHD
practitioners can choose. Potential activities include a tar-
geted workshop in evidence-based public health, technical
assistance through a knowledge broker, targeted messages,
and organizational changes to create climates that are
more supportive of evidence-based approaches to diabetes
and chronic disease control (see Additional file 2). Add-
itional dissemination intervention menu activities will be
generated based on the local-level needs assessment de-
scribed previously. This approach circumvents the disad-
vantages of a universal or standard process that is unlikely
to be effective across the 12 participating LHDs. To re-
duce exposure variability within the intervention, LHDs
will be asked to choose a minimum of three and max-
imum of four activities from the menu. This study will not
attempt to evaluate a single dissemination intervention
but will pursue active, multi-modal approaches, since
these are supported in the literature [62, 92–94]. The ini-
tial dissemination activity for each group of LHDs will be
a multi-day in-person training course [95].
Evaluation for phase 2
To evaluate the effects of intervention strategies, key
variables that relate to the dissemination stages of
awareness, adoption, implementation, and maintenance
(Fig. 1a) will be measured as well as a two-part adoption
variable based on the record review. Primary outcomes
will be measured through individual- and organization-
level self-report survey items determined through phase
1 (see Table 1). Quantitative data will come from three
instruments: the national survey instrument, the record
abstraction tool, and a social network analysis instru-
ment to be developed with input from the study advisory
group. Survey instrument data will be collected from in-
dividual local public health practitioners during the pre-
intervention period and at the three 8-month intervals/
steps during the intervention period. Records for data
abstraction will be obtained from LHDs, and social net-
work analysis instrument data will be collected from in-
dividual local public health and key partner employees
at pre-intervention and at the 24-month time point, i.e.,
the end of the intervention period.
A variety of individual-level variables will be captured
from the national survey instrument, including sociode-
mographic characteristics (e.g., age, education level), their
health promotion practices, and individual-level know-
ledge about EBPPs. Organizational level variables will be
tied to Institutional Theory and will include the size of the
agency in which the respondent works, the agency support
for EBPPs (derived from the national survey instrument),
and agency/administrator awareness of EBPPs. At the
local level, a variety of relevant archival variables are avail-
able and may be included: LHD expenditures on chronic
diseases and health behaviors from all sources, mortality
rate for diabetes as underlying cause (diabetes disparity),
percent of population of non-Hispanic white race/ethni-
city, presence of a local board of health, and dominant
local political party. Both at the individual level and
organizational level, we will measure exposure to the dis-
semination activities to determine whether higher expos-
ure leads to more progression across the dissemination
stages. Additionally, we will track which EBPPs are being
implemented, and how closely fidelity is maintained as
specific EBPPs are implemented across LHDs and adapted
to address disparities and other contextual factors. As
phase 2 intervention strategies are implemented with
LHDs, process measures will be captured, such as staff
time needed to coordinate the trainings and participation
rates across sites.
Data analyses
Using the data collected from the cross-sectional phase 1
national survey, confirmatory factor analysis will be con-
ducted to reduce and refine the dissemination stage vari-
able groupings while examining construct validity of the
measures. Descriptive statistics will be calculated for all
variables. Chi-squared and t tests will be done to compare
subgroups of participants, and multivariate linear and lo-
gistic regression modeling will be conducted to test for
hypothesized associations. For phase 2, the leading statis-
tical method is a generalized linear mixed effect
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regression, which has the following form:
g(E(Yijk)) = μ + αi + γik + βj + θ × Xij + λ × Zik, where Yijk
is the outcome measurement for subject k at step j in
LHD i. g(.) is link function of expectation of Yijk to a lin-
ear predictor. For binary outcome, g(.) is logit, and for
continuous outcome g(.) is identity. αi is cluster-specific
random effects, capturing the correlation among outcome
measurements from subjects in the same LHD; γik is
subject-specific random effects, capturing the correlation
among outcome measurements within same subject over
time; βj is the fixed effect for time j; Xij is an intervention
indicator (1 if LHD i in intervention condition at time j, 0
otherwise); θ is the intervention effect; Zik is a vector of
subject-level covariates for adjustment; and λ is the a vec-
tor of regression coefficients for these covariates.
Study status
The study is currently in progress. Some phase 1 activities
have been completed as previously indicated, including
survey cognitive response testing and test-retest reliability
data collection. The local-level needs assessment, includ-
ing the qualitative assessment of organization and broader
system factors that facilitate or hinder dissemination of
EBDM and EBPPs for diabetes control, is close to comple-
tion. The planning of phase 2, the stepped-wedge cluster
randomized trial, is in progress. LHDs selection criteria
have been established and recruitment is underway.
Discussion
This study has the likelihood to be innovative in numer-
ous ways. To our knowledge, this is the first large-scale
study of its kind among LHDs in the USA that seeks to
further EBDM in diabetes and chronic disease control.
This study is also among the first to (1) develop, test, and
use measures of dissemination and implementation of
EBPPs that are currently lacking [61, 62, 93] and (2) apply
constructs and measures from Institutional Theory with
Diffusion of Innovations theory, a widely used theory in
public health and dissemination research. This study will
apply known dissemination strategies and lessons from
Canada [86, 96, 97]. The use of social network analysis has
high potential to explain key relationships, network struc-
tures associated with evidence diffusion (e.g., centralized
versus decentralized), and network predictors of dissemin-
ation [98–100]. In addition, this study uses a stakeholder-
driven, flexible approach, with selection of dissemination
strategies that have the greatest feasibility among the
LHDs enrolled in the phase 2 evaluation study. A project
of this scale can provide a replicable model for dissemin-
ation and has the potential to begin to shift the paradigm
on how research can be more effectively scaled-up across
the USA to those in an ideal position to use the evidence.
The study is subject to limitations. Due to the com-
plexity of the phase 2 evaluation study, it will be
confined to LHDs in Missouri. However, Missouri is
often considered a microcosm of the USA due to
how closely it mirrors the USA on a number of key
characteristics including urban-rural split, diabetes
disparities, race, age, and education level [101]. In
addition, LHDs in Missouri operate independently of
each other and are independent of state and federal
public health agencies like most LHDs in the USA
[84]. The pool of eligible LHDs is limited to primarily
large and some mid-sized LHDs to ensure adequate
sample size for self-report data collection. In addition,
there is a limited pool of individuals that can be re-
cruited for self-report data collection. Another limita-
tion to our evaluation efforts is study activities will
be completed within a dynamic natural setting that
includes a push for use of EBPPs by the state health
department and other funders, thus making it chal-
lenging to find differences between LHDs and attrib-
uting this difference to the intervention. With data
collection triangulation efforts, we increase the study’s
capability to examine our multi-approach influence.
An approach with LHDs presents challenges including
employee turnover and funding constraints. In phase
2, employee turnover will be monitored and managed
through regular communication with practitioners in
the 12 LHDs. This study will seek to address funding
constraints and challenges by training employees on
communicating prevention and management priorities
to key decision-makers, making public health evidence
available in ways that save employees time to access
and digest, and providing technical assistance in grant
writing and diversification of funding sources.
In conclusion, a reduction in diabetes burden and dis-
parities is possible with the application of programs and
policies proven for diabetes and chronic disease control
[10]. The findings from this study will further a growing
knowledge base for how best to support use of evidence-
based public health practice among LHDs.
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